Life expectancy and mortality of people with and without diabetes in Aotearoa | New Zealand: A national cohort study
PLOS One · 2026
DOI: 10.1371/journal.pone.0345892 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, 2026. Verfasst von Francois Verster und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Waikato Hospital, Health New Zealand, Te Whatu Ora, Waikato, New Zealand. Hauptthemen laut MEDLINE: Life Expectancy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Waikato Health Trust Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes mellitus (DM) is a significant driver of excess morbidity and premature mortality, though few contemporary or locally-derived data quantify this impact on New Zealanders, particularly Māori and Pacific Peoples. This prospective, national population study examines the life expectancy (LE) for New Zealanders with and without DM, and characterises mortality rates.
Methods
Data from 01/01/2015 to 31/12/2019 housed in the Integrated Data Infrastructure, including the Virtual Diabetes Registry and Health New Zealand Mortality Collection, were linked. Estimated remaining LE years were calculated using abridged period life tables using the Chiang method for those with type 1 diabetes (T1D), type 2 diabetes (T2D), and without DM. Sub-group analysis by ethnicity was completed. Five-year cause-specific mortality rates per 100,000 people were compared by DM group.
Findings
T1D and T2D prevalence was 0.4% and 5.5% in the overall sample ( n = 4,505,478). Considerable ethnic differences in LE were evident, for example a 13-, 17.1-, and 24.5-year loss in remaining LE years was seen in men aged 0–19 years with T1D in the overall, Māori, and Pacific Peoples groups respectively compared to those without DM. An age-dependent reduction in remaining life expectancy years was also evident; for example an 8.6 (8.5–8.7) year reduction seen in females with DM aged 0–4, and 4.0 (4.0–4.1) year reduction for women with DM aged 65–69. Those with DM had higher cause-specific death rates.
Interpretation
DM is associated with age-dependent reductions in LE across the entire lifespan, with disproportionately higher LE loss seen in Māori and Pacific Peoples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Endocrinology, Waikato Hospital, Health New Zealand, Te Whatu Ora, Waikato, New Zealand.
- Department of Paediatrics and Child Health, Ōtākou Whakaihu Waka, University of Otago, Otago, New Zealand.
- Te Kaupeka Oranga, Faculty of Health, Te Whare Wananga o Waitaha, University of Canterbury, Christchurch, New Zealand.
- School of Clinical Medicine, Primary Care Clinical Unit, University of Queensland, Brisbane, Australia.
- Division of Health, University of Waikato, Waikato, New Zealand.
- Waikato Regional Diabetes Service, Health New Zealand, Te Whatu Ora, Waikato, New Zealand.
ORCID-Profile: Francois Verster
Förderung
- Waikato Health Trust Fund
Zitieren
APA
Verster, F., Bowden, N., Schluter, P. J., Chepulis, L., & Paul, R. G. (2026). Life expectancy and mortality of people with and without diabetes in Aotearoa | New Zealand: A national cohort study. PLOS One. https://doi.org/10.1371/journal.pone.0345892
Vancouver
Verster F, Bowden N, Schluter PJ, Chepulis L, Paul RG. Life expectancy and mortality of people with and without diabetes in Aotearoa | New Zealand: A national cohort study. PLOS One. 2026. doi:10.1371/journal.pone.0345892
BibTeX
@article{Verster2026,
author = {Verster, Francois and Bowden, Nicholas and Schluter, Philip J and Chepulis, Lynne and Paul, Ryan G},
title = {Life expectancy and mortality of people with and without diabetes in Aotearoa | New Zealand: A national cohort study},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0345892}
}
EUVIMED